Logo image of 1ISRG.MI

INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis

BIT:1ISRG - Euronext Milan - US46120E6023 - Common Stock - Currency: EUR

456.55  -32.7 (-6.68%)

Fundamental Rating

6

Taking everything into account, 1ISRG scores 6 out of 10 in our fundamental rating. 1ISRG was compared to 64 industry peers in the Health Care Equipment & Supplies industry. 1ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1ISRG shows excellent growth, but is valued quite expensive already. These ratings would make 1ISRG suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

1ISRG had positive earnings in the past year.
In the past year 1ISRG had a positive cash flow from operations.
Each year in the past 5 years 1ISRG has been profitable.
1ISRG had a positive operating cash flow in each of the past 5 years.
1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

With an excellent Return On Assets value of 12.88%, 1ISRG belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
1ISRG has a Return On Equity of 14.47%. This is in the better half of the industry: 1ISRG outperforms 79.69% of its industry peers.
The Return On Invested Capital of 1ISRG (10.45%) is better than 81.25% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1ISRG is in line with the industry average of 8.65%.
The last Return On Invested Capital (10.45%) for 1ISRG is above the 3 year average (10.24%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.88%
ROE 14.47%
ROIC 10.45%
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)10.24%
ROIC(5y)9.93%
1ISRG.MI Yearly ROA, ROE, ROIC1ISRG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With an excellent Profit Margin value of 28.41%, 1ISRG belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
1ISRG's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 28.28%, 1ISRG belongs to the top of the industry, outperforming 96.88% of the companies in the same industry.
In the last couple of years the Operating Margin of 1ISRG has declined.
The Gross Margin of 1ISRG (67.09%) is better than 67.19% of its industry peers.
In the last couple of years the Gross Margin of 1ISRG has remained more or less at the same level.
Industry RankSector Rank
OM 28.28%
PM (TTM) 28.41%
GM 67.09%
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
1ISRG.MI Yearly Profit, Operating, Gross Margins1ISRG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

1ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, 1ISRG has more shares outstanding
Compared to 5 years ago, 1ISRG has more shares outstanding
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1ISRG.MI Yearly Shares Outstanding1ISRG.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
1ISRG.MI Yearly Total Debt VS Total Assets1ISRG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 58.66 indicates that 1ISRG is not in any danger for bankruptcy at the moment.
The Altman-Z score of 1ISRG (58.66) is better than 100.00% of its industry peers.
There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 58.66
ROIC/WACC1.15
WACC9.11%
1ISRG.MI Yearly LT Debt VS Equity VS FCF1ISRG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

1ISRG has a Current Ratio of 4.98. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.98, 1ISRG belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
A Quick Ratio of 3.97 indicates that 1ISRG has no problem at all paying its short term obligations.
1ISRG has a Quick ratio of 3.97. This is amongst the best in the industry. 1ISRG outperforms 95.31% of its industry peers.
Industry RankSector Rank
Current Ratio 4.98
Quick Ratio 3.97
1ISRG.MI Yearly Current Assets VS Current Liabilites1ISRG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.76% over the past year.
1ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
1ISRG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.08%.
The Revenue has been growing by 13.27% on average over the past years. This is quite good.
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%

3.2 Future

1ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.45% yearly.
Based on estimates for the next years, 1ISRG will show a quite strong growth in Revenue. The Revenue will grow by 14.12% on average per year.
EPS Next Y8.84%
EPS Next 2Y12.18%
EPS Next 3Y13.88%
EPS Next 5Y14.45%
Revenue Next Year18.08%
Revenue Next 2Y16.61%
Revenue Next 3Y16.15%
Revenue Next 5Y14.12%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
1ISRG.MI Yearly Revenue VS Estimates1ISRG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
1ISRG.MI Yearly EPS VS Estimates1ISRG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 68.35 indicates a quite expensive valuation of 1ISRG.
The rest of the industry has a similar Price/Earnings ratio as 1ISRG.
The average S&P500 Price/Earnings ratio is at 26.55. 1ISRG is valued rather expensively when compared to this.
1ISRG is valuated quite expensively with a Price/Forward Earnings ratio of 56.56.
Based on the Price/Forward Earnings ratio, 1ISRG is valued a bit more expensive than 64.06% of the companies in the same industry.
1ISRG is valuated expensively when we compare the Price/Forward Earnings ratio to 22.40, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 68.35
Fwd PE 56.56
1ISRG.MI Price Earnings VS Forward Price Earnings1ISRG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than 65.63% of the companies in the same industry.
1ISRG's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 107.16
EV/EBITDA 64.66
1ISRG.MI Per share data1ISRG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of 1ISRG may justify a higher PE ratio.
1ISRG's earnings are expected to grow with 13.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.73
PEG (5Y)5.95
EPS Next 2Y12.18%
EPS Next 3Y13.88%

0

5. Dividend

5.1 Amount

1ISRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTUITIVE SURGICAL INC

BIT:1ISRG (6/11/2025, 7:00:00 PM)

456.55

-32.7 (-6.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-22 2025-04-22/amc
Earnings (Next)07-16 2025-07-16/amc
Inst Owners89.44%
Inst Owner ChangeN/A
Ins Owners0.5%
Ins Owner ChangeN/A
Market Cap163.64B
Analysts79.49
Price Target526.29 (15.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.91%
Min EPS beat(2)3.05%
Max EPS beat(2)20.76%
EPS beat(4)4
Avg EPS beat(4)11.89%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)8.01%
EPS beat(12)10
Avg EPS beat(12)4.94%
EPS beat(16)13
Avg EPS beat(16)5.44%
Revenue beat(2)2
Avg Revenue beat(2)3.11%
Min Revenue beat(2)1.09%
Max Revenue beat(2)5.12%
Revenue beat(4)2
Avg Revenue beat(4)1.5%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)3
Avg Revenue beat(8)0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)0.86%
PT rev (1m)2.47%
PT rev (3m)-15.2%
EPS NQ rev (1m)-2%
EPS NQ rev (3m)-2.19%
EPS NY rev (1m)-2.89%
EPS NY rev (3m)-2.85%
Revenue NQ rev (1m)0.25%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)0.69%
Valuation
Industry RankSector Rank
PE 68.35
Fwd PE 56.56
P/S 21.46
P/FCF 107.16
P/OCF 68.48
P/B 10.93
P/tB 11.17
EV/EBITDA 64.66
EPS(TTM)6.68
EY1.46%
EPS(NY)8.07
Fwd EY1.77%
FCF(TTM)4.26
FCFY0.93%
OCF(TTM)6.67
OCFY1.46%
SpS21.27
BVpS41.76
TBVpS40.86
PEG (NY)7.73
PEG (5Y)5.95
Profitability
Industry RankSector Rank
ROA 12.88%
ROE 14.47%
ROCE 13.94%
ROIC 10.45%
ROICexc 14.17%
ROICexgc 14.58%
OM 28.28%
PM (TTM) 28.41%
GM 67.09%
FCFM 20.03%
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)10.24%
ROIC(5y)9.93%
ROICexc(3y)18.39%
ROICexc(5y)17.67%
ROICexgc(3y)19.32%
ROICexgc(5y)18.71%
ROCE(3y)13.65%
ROCE(5y)13.23%
ROICexcg growth 3Y10.09%
ROICexcg growth 5Y3.3%
ROICexc growth 3Y10.33%
ROICexc growth 5Y3.99%
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 185.49%
Cap/Sales 11.31%
Interest Coverage 250
Cash Conversion 91.16%
Profit Quality 70.49%
Current Ratio 4.98
Quick Ratio 3.97
Altman-Z 58.66
F-Score6
WACC9.11%
ROIC/WACC1.15
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
EPS Next Y8.84%
EPS Next 2Y12.18%
EPS Next 3Y13.88%
EPS Next 5Y14.45%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%
Revenue Next Year18.08%
Revenue Next 2Y16.61%
Revenue Next 3Y16.15%
Revenue Next 5Y14.12%
EBIT growth 1Y32.36%
EBIT growth 3Y8.64%
EBIT growth 5Y11.3%
EBIT Next Year33.95%
EBIT Next 3Y22.85%
EBIT Next 5Y19.86%
FCF growth 1Y73.18%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y66.62%
OCF growth 3Y4.95%
OCF growth 5Y8.61%